Literature DB >> 15584033

Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.

Ian S Zagon1, Torre B Ruth, Patricia J McLaughlin.   

Abstract

The subcellular distributions of the opioid growth factor (OGF), [Met(5)]-enkephalin, and opioid growth factor receptor (OGFr) in the epithelium of the rat tongue were determined in order to reveal structure-function relationships. Laser scanning confocal microscopic analysis showed that both OGF and OGFr were colocalized in the paranuclear cytoplasm and in the nuclei of keratinocytes in the stratum basale. Using immunoelectron microscopy and postembedding techniques, double labeling experiments disclosed that complexes of OGF-OGFr were colocalized on the outer nuclear envelope, in the paranuclear cytoplasm, perpendicular to the nuclear envelope in a putative nuclear pore complex, and in the nucleus adjacent to heterochromatin. Anti-OGF IgG alone was detected in the cytoplasm, and anti-OGFr IgG alone was associated with the outer nuclear envelope. Study of chronic treatment with the opioid antagonist, naltrexone (NTX), which blocks opioid-receptor binding, revealed the presence of OGFr immunoreactivity alone in the cytoplasm and the nucleus; some OGF-OGFr complexes were also observed. Colocalization of OGFr and karyopherin (importin) beta was recorded in the cytoplasm and nucleus. These results in tongue epithelium are the first to suggest that OGFr resides on the outer nuclear envelope, where OGF interacts with OGFr; that the OGF-OGFr complex translocates between cytoplasm and nucleus at the nuclear pore; and that the nuclear localization signal of OGFr interacts with karyopherin beta for nuclear transport. These novel data also indicate that signal transduction for cell proliferation appears to involve an OGF-OGFr complex that interfaces with chromatin in the nucleus. Moreover, the unique finding that OGFr was found in the cytoplasm and nucleus in NTX-treated specimens may suggest that NTX-OGFr complexes have the same pathway as OGF-OGFr. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15584033     DOI: 10.1002/ar.a.20161

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  10 in total

1.  Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; William A Banks; Ian S Zagon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

Review 2.  Opioid growth factor and the treatment of human pancreatic cancer: a review.

Authors:  Ian S Zagon; Patricia J McLaughlin
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

3.  Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.

Authors:  Matthew S Klocek; Joseph W Sassani; Renee N Donahue; Patricia J McLaughlin; Ian S Zagon
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-12       Impact factor: 4.799

4.  The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.

Authors:  Diego M Avella; Eric T Kimchi; Renee N Donahue; Hephzibah Rani S Tagaram; Patricia J McLaughlin; Ian S Zagon; Kevin F Staveley-O'Carroll
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

5.  The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.

Authors:  Fan Cheng; Patricia J McLaughlin; Michael F Verderame; Ian S Zagon
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

6.  Inhibition of the growth of human melanoma cells by methionine enkephalin.

Authors:  Dong-Mei Wang; Guang-Chuan Wang; Jing Yang; Nicolas P Plotnikoff; Noreen Griffin; Yu-Man Han; Rui-Qun Qi; Xing-Hua Gao; Feng-Ping Shan
Journal:  Mol Med Rep       Date:  2016-11-14       Impact factor: 2.952

7.  The Novel Secreted Meloidogyne incognita Effector MiISE6 Targets the Host Nucleus and Facilitates Parasitism in Arabidopsis.

Authors:  Qianqian Shi; Zhenchuan Mao; Xiaoping Zhang; Jian Ling; Runmao Lin; Xi Zhang; Rui Liu; Yunsheng Wang; Yuhong Yang; Xinyue Cheng; Bingyan Xie
Journal:  Front Plant Sci       Date:  2018-03-23       Impact factor: 5.753

8.  Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.

Authors:  Patricia J McLaughlin; Ian S Zagon; Sunny S Park; Andrea Conway; Renee N Donahue; David Goldenberg
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430

9.  Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells.

Authors:  Ayesha S Don-Salu-Hewage; Siu Yuen Chan; Kathleen M McAndrews; Mahandranauth A Chetram; Michelle R Dawson; Danaya A Bethea; Cimona V Hinton
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 10.  The Local Neuropeptide System of Keratinocytes.

Authors:  Nicola Cirillo
Journal:  Biomedicines       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.